All ONS Member Community

Expand all | Collapse all

VYXEOS (daunorubicin and cytarabine liposome) poll

  • 1.  VYXEOS (daunorubicin and cytarabine liposome) poll

    Posted 13 days ago
    Hi
    Looking to get a pulse on whether your institution classifies this drug as a "vessicant" or an "irritant." The PI is less than helpful as it states that daunorubicin is a vesicant (yes, we already know that!) but does not state whether this liposome combination is considered as such. (Doxil is not considered a vesicant even though it contains doxorubicin.)

    Interested in hearing from all of you.

    Thanks in advance.

    Seth

    ------------------------------
    Seth Eisenberg RN ASN OCN BMTCN
    PROFESSIONAL PRACTICE COORDINATOR, INFUSION SERVIC
    Seattle Cancer Care Alliance
    Federal Way WA
    ------------------------------


  • 2.  RE: VYXEOS (daunorubicin and cytarabine liposome) poll

    Posted 13 days ago

    We treat as an irritant.

     

    Joy

    Joy Lombardi, BSN, RN, OCN

    Nursing Director

    Huntsman Outpatient Infusion

    Huntsman Cancer Institute

    801-585-9822

    Joy.lombardi@hci.utah.edu

     

                  

     

    Changing the DNA of Cancer Care

     

    u_health_email